COLUMBIA, Md. (March 8, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $400,000 in two technology start-ups. TEDCO’s Seed Fund invests in early-stage, technology and life sciences companies and includes gap financing.
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
Shares of Altimmune Inc. ALT were down 4.8% in trading on Thursday after the company said it started enrolling participants in a Phase 1 clinical trial for its COVID-19 vaccine candidate. Altimmune is developing a single-dose nasal spray vaccine. The study is expected to enroll up to 180 healthy adults between the ages of 18 and 55 years old, who will receive one of three doses of the experimental vaccine. The company said it expects to share the first batch of clinical data from this trial in the second quarter of this year. Altimmune’s stock has soared 969.9% over the past 12 months, while the broader S&P 500 SPX is up 21.7%.
Are you a BioHealth entrepreneur working with an academic institution on your oncology R&D? The NCI SBIR Development Center has announced a new funding opportunity to support academic post-doc transitions to industry. This new and unique Fast-Track only award structure comprises a Phase I STTR that transitions to a Phase II SBIR. An STTR award is a collaborative award made to small businesses working closely with a university deadline to apply by 3/25. For more information, check online: Small Business Transition Grant | NCI: SBIR & STTR (cancer.gov)
Image: https://sbir.cancer.gov/funding/sbtg From Video
Emergent BioSolutions’ contract development and manufacturing (CDMO) business is playing a crucial role in supporting the battle against COVID-19. The company has contracted with multiple vaccine makers, including AstraZeneca and Johnson & Johnson, to manufacture the preventative medications.
It’s a critical role not taken lightly by the employees in the company’s two Baltimore-based facilities. Sean Kirk, executive vice president of Manufacturing and Technical Operations at Emergent, said the importance of the work taken on by Emergent, as well as the biopharma industry at large to battle the pandemic is not lost on him.
Alexandria Venture Investments Senior Associate, Conley Jones, virtually sits down with Rich Bendis on BioTalk to discuss Venture Trends, Investment Goals, and their National Footprint
Listen now on Apple http://apple.co/3sCbtaH, Google http://bit.ly/3kG3MgX, Spotify http://spoti.fi/3kKNGmt, and TuneIn http://bit.ly/3uGvJtJ.
George Mason University President Gregory Washington on Monday announced he has formed an advisory roundtable of nearly 30 regional business executives and community leaders to focus on the university’s innovation initiative.
The President’s Innovation Advisory Council will focus on issues such as GMU’s efforts to increase the pipeline of tech workers. George Mason’s innovation initiative includes $235 million in General Assembly funding to produce approximately 30% of the 25,000 undergraduate and graduate majors as part of the state’s Tech Talent Investment Program.
Image: Concept rendering of George Mason University’s Institute for Digital InnovAtion (IDIA) in Arlington
A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.
The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.
The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.
Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.
Sponsored by: First National Bank, Olive, and TEDCO
SoPE + GW Startup Pitch Application Apply now to pitch at our March 24th Event: Pitch Perfect II: In Action!
Application is limited to SoPE members or those affiliated with George Washington University (students, staff, licensees, etc). Limited spots available. Submission does not guarantee acceptance.
Submission deadline: March 5th, 2021.
